Lista de obras - Mohamed Karmali - Dominio Público Uruguay

A common polymorphism near the interleukin-6 gene modifies the association between dietary fat intake and insulin sensitivity.

artículo científico publicado en 2012

Age-specific frequencies of antibodies to Escherichia coli verocytotoxins (Shiga toxins) 1 and 2 among urban and rural populations in southern Ontario

artículo científico publicado en 2003

Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections

artículo científico publicado en 2002

Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome

artículo científico publicado en 2001

Antigenic heterogeneity of Escherichia coli verotoxins

artículo científico publicado en 1986

Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease

artículo científico publicado en 2003

Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection

artículo científico publicado en 2006

Bovine reservoir for verotoxin-producing Escherichia coli O157:H7.

artículo científico publicado en 1987

Campylobacter enteritis in children

scientific article published on 01 April 1979

Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease.

artículo científico publicado en 2010

Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE

artículo científico publicado en 2007

Clinical relevance of a serological cross-reaction between Escherichia coli O157 and Brucella abortus

artículo científico publicado en 1987

Common variants of the vitamin D binding protein gene and adverse health outcomes

artículo científico publicado en 2013

Cross-protection against challenge by intravenous Escherichia coli verocytotoxin 1 (VT1) in rabbits immunized with VT2 toxoid

scientific article published on 01 January 2002

Dietary patterns and ethnicity are associated with distinct plasma proteomic groups

scientific article published on 28 December 2011

ESCHERICHIA COLI CYTOTOXIN, HAEMOLYTIC-URAEMIC SYNDROME, AND HAEMORRHAGIC COLITIS

artículo científico publicado en 1983

Effects of polymorphisms in nucleotide-binding oligomerization domains 1 and 2 on biomarkers of the metabolic syndrome and type II diabetes.

artículo científico publicado en 2012

Enterohemorrhagic Escherichia coli O157:H7 gene expression profiling in response to growth in the presence of host epithelia

artículo científico publicado en 2009

Escherichia coli shiga-like toxins induce apoptosis and cleavage of poly(ADP-ribose) polymerase via in vitro activation of caspases

artículo científico publicado en 2002

Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine?

artículo científico publicado en 2010

Factors in the emergence of serious human infections associated with highly pathogenic strains of shiga toxin-producing Escherichia coli

artículo científico publicado en 2018

FatalBordetella PertussisInfection: Report of Two Cases with Novel Pathologic Findings

artículo científico publicado en 1996

From the National Institutes of Health. Summary of the International Symposium and Workshop on Infections due to Verocytotoxin (Shiga-like toxin)-producing Escherichia coli

artículo científico publicado en 1988

Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. ⬇️

artículo científico publicado en 2011

Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes

artículo científico publicado en 2010

Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli.

artículo científico publicado en 2008

Hospital-acquired Escherichia coli O157:H7 associated haemolytic uraemic syndrome in a nurse

artículo científico publicado en 1988

Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome

artículo científico publicado en 2009

Human Escherichia coli O157[ratio ]H7 infection associated with the consumption of unpasteurized goat's milk ⬇️

artículo científico publicado el 1 de diciembre de 1997

Identification of four fimbria-encoding genomic islands that are highly specific for verocytotoxin-producing Escherichia coli serotype O157 strains

artículo científico publicado en 2005

In silico genomic analyses reveal three distinct lineages of Escherichia coli O157:H7, one of which is associated with hyper-virulence

artículo científico publicado en 2009

Infection by Shiga toxin-producing Escherichia coli: an overview

artículo científico publicado en 2004

Isolation and genetic characterization of a coinfection of non-O157 Shiga toxin-producing Escherichia coli

artículo científico publicado en 2007

Lineage and host source are both correlated with levels of Shiga toxin 2 production by Escherichia coli O157:H7 strains.

artículo científico publicado en 2009

Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains

artículo científico publicado en 2008

Multiple seropathotypes of verotoxin-producing Escherichia coli (VTEC) disrupt interferon-gamma-induced tyrosine phosphorylation of signal transducer and activator of transcription (Stat)-1.

artículo científico publicado en 2006

Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function

artículo científico publicado en 2005

PATHOGENESIS OF HAEMOLYTIC URAEMIC SYNDROME

artículo científico publicado en 1987

Plasma 25-hydroxyvitamin D, hormonal contraceptive use, and cardiometabolic disease risk in an ethnically diverse population of young adults

artículo científico publicado en 2013

Plasma Vitamin D and Biomarkers of Cardiometabolic Disease Risk in Adult Canadians, 2007–2009 ⬇️

artículo científico publicado el 6 de junio de 2013

Polymorphisms in Toll-like receptor 4 are associated with factors of the metabolic syndrome and modify the association between dietary saturated fat and fasting high-density lipoprotein cholesterol

artículo científico publicado en 2011

Prospects for preventing serious systemic toxemic complications of Shiga toxin-producing Escherichia coli infections using Shiga toxin receptor analogues

scientific article published in 2004

REINFECTION WITH CAMPYLOBACTER JEJUNI

artículo científico publicado en 1981

Rapid genoserotyping tool for classification of Salmonella serovars.

artículo científico publicado en 2011

Repression of intracellular virulence factors in Salmonella by the Hha and YdgT nucleoid-associated proteins

artículo científico publicado en 2007

SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system

artículo científico publicado en 2005

Serological differences between verocytotoxin 2 and shiga-like toxin II.

artículo científico publicado en 1988

Serological response of Shiga toxin-producing Escherichia coli type III secreted proteins in sera from vaccinated rabbits, naturally infected cattle, and humans

artículo científico publicado en 2011

Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells

artículo científico publicado en 2006

Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome

artículo científico publicado en 2002

Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools ⬇️

artículo científico publicado el 19 de marzo de 1983

Susceptibility of Campylobacter species to metronidazole, its bioactive metabolites and tinidazole

artículo científico publicado en 1987

Susceptibility ofCampylobacter species to niridazole

artículo científico publicado en 1986

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. 1985.

artículo científico publicado en 2004

The continuing evolution of a bacterial pathogen

artículo científico publicado en 2008

The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.

artículo científico publicado en 1988

Use of an ammonia electrode to study bacterial deamination of amino acids with special reference to D-asparagine breakdown by campylobacters.

artículo científico publicado en 1984

Use of comparative genomics as a tool to assess the clinical and public health significance of emerging Shiga toxin-producing Escherichia coli serotypes ⬇️

artículo científico publicado el 13 de abril de 2005

Verocytotoxin-producing Escherichia coli (VTEC).

artículo científico publicado en 2009

Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe.

artículo científico publicado en 1996

Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress.

artículo científico publicado en 2011

Lista de obras de Mohamed Karmali

A common polymorphism near the interleukin-6 gene modifies the association between dietary fat intake and insulin sensitivity.

Age-specific frequencies of antibodies to Escherichia coli verocytotoxins (Shiga toxins) 1 and 2 among urban and rural populations in southern Ontario

Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections

Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome

Antigenic heterogeneity of Escherichia coli verotoxins

Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease

Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection

Bovine reservoir for verotoxin-producing Escherichia coli O157:H7.

Campylobacter enteritis in children

Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease.

Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE

Clinical relevance of a serological cross-reaction between Escherichia coli O157 and Brucella abortus

Common variants of the vitamin D binding protein gene and adverse health outcomes

Cross-protection against challenge by intravenous Escherichia coli verocytotoxin 1 (VT1) in rabbits immunized with VT2 toxoid

Dietary patterns and ethnicity are associated with distinct plasma proteomic groups

ESCHERICHIA COLI CYTOTOXIN, HAEMOLYTIC-URAEMIC SYNDROME, AND HAEMORRHAGIC COLITIS

Effects of polymorphisms in nucleotide-binding oligomerization domains 1 and 2 on biomarkers of the metabolic syndrome and type II diabetes.

Enterohemorrhagic Escherichia coli O157:H7 gene expression profiling in response to growth in the presence of host epithelia

Escherichia coli shiga-like toxins induce apoptosis and cleavage of poly(ADP-ribose) polymerase via in vitro activation of caspases

Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine?

Factors in the emergence of serious human infections associated with highly pathogenic strains of shiga toxin-producing Escherichia coli

FatalBordetella PertussisInfection: Report of Two Cases with Novel Pathologic Findings

From the National Institutes of Health. Summary of the International Symposium and Workshop on Infections due to Verocytotoxin (Shiga-like toxin)-producing Escherichia coli

Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. ⬇️

Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes

Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli.

Hospital-acquired Escherichia coli O157:H7 associated haemolytic uraemic syndrome in a nurse

Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome

Human Escherichia coli O157[ratio ]H7 infection associated with the consumption of unpasteurized goat's milk ⬇️

Identification of four fimbria-encoding genomic islands that are highly specific for verocytotoxin-producing Escherichia coli serotype O157 strains

In silico genomic analyses reveal three distinct lineages of Escherichia coli O157:H7, one of which is associated with hyper-virulence

Infection by Shiga toxin-producing Escherichia coli: an overview

Isolation and genetic characterization of a coinfection of non-O157 Shiga toxin-producing Escherichia coli

Lineage and host source are both correlated with levels of Shiga toxin 2 production by Escherichia coli O157:H7 strains.

Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains

Multiple seropathotypes of verotoxin-producing Escherichia coli (VTEC) disrupt interferon-gamma-induced tyrosine phosphorylation of signal transducer and activator of transcription (Stat)-1.

Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function

PATHOGENESIS OF HAEMOLYTIC URAEMIC SYNDROME

Plasma 25-hydroxyvitamin D, hormonal contraceptive use, and cardiometabolic disease risk in an ethnically diverse population of young adults

Plasma Vitamin D and Biomarkers of Cardiometabolic Disease Risk in Adult Canadians, 2007–2009 ⬇️

Polymorphisms in Toll-like receptor 4 are associated with factors of the metabolic syndrome and modify the association between dietary saturated fat and fasting high-density lipoprotein cholesterol

Prospects for preventing serious systemic toxemic complications of Shiga toxin-producing Escherichia coli infections using Shiga toxin receptor analogues

REINFECTION WITH CAMPYLOBACTER JEJUNI

Rapid genoserotyping tool for classification of Salmonella serovars.

Repression of intracellular virulence factors in Salmonella by the Hha and YdgT nucleoid-associated proteins

SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system

Serological differences between verocytotoxin 2 and shiga-like toxin II.

Serological response of Shiga toxin-producing Escherichia coli type III secreted proteins in sera from vaccinated rabbits, naturally infected cattle, and humans

Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells

Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome

Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools ⬇️

Susceptibility of Campylobacter species to metronidazole, its bioactive metabolites and tinidazole

Susceptibility ofCampylobacter species to niridazole

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. 1985.

The continuing evolution of a bacterial pathogen

The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.

Use of an ammonia electrode to study bacterial deamination of amino acids with special reference to D-asparagine breakdown by campylobacters.

Use of comparative genomics as a tool to assess the clinical and public health significance of emerging Shiga toxin-producing Escherichia coli serotypes ⬇️

Verocytotoxin-producing Escherichia coli (VTEC).

Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe.

Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress.